Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Neovasc Inc.
DescriptionDevice implanted to modulate blood flow from coronary sinus vein
Molecular Target
Mechanism of Action 
Therapeutic ModalityMedical Devices: Other device
Latest Stage of DevelopmentMarketed
Standard IndicationAngina
Indication DetailsTreat refractory angina
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today